In a study involving 734 CRC patients, 90 (12%) had SMAD4 mutations, and the missense mutations at R361 and P356 in the MH2 domain were the most common SMAD4 alterations, as verified by full-length sequencing. Here, SMAD4 is linked to colorectal carcinoma.